Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-006389
Filing Date
2023-02-02
Accepted
2023-02-02 18:21:44
Documents
2
Period of Report
2023-02-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2934
2 POA DOCUMENT poa.txt EX-24 3011
  Complete submission text file 0001209191-23-006389.txt   7434
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Issuer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O STRUCTURE THERAPEUTICS INC. 611 GATEWAY BLVD., SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address
Ma Yingli (Reporting) CIK: 0001963664 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41608 | Film No.: 23582801